Pfizer Announces Conclusion of Consent Solicitation For $22.5 Million of Debt

Pfizer

today announced the results of its solicitation of consents to amend certain provisions of the indentures with respect to the following outstanding debt securities of its wholly-owned subsidiary Pharmacia Corporation: Debt Security CUSIP No. Outstanding Principal Amount 6.47% Notes due 2018 61167HBK8 $ 20,000,000 8.70% Debentures due 2021 71713UAR3 $ 2,507,000 Based on information provided by D.F. King & Co., Inc., the information and tabulation agent for the consent solicitation, as of 5:00 p.m., New York City time, on Monday, August 27, 2012, the required consents from holders of the $20,000,000 outstanding aggregate principal amount of 6.47% Notes due 2018, CUSIP No. 61167HBK8, and outstanding aggregate principal amount of $2,507,000 8.70% Debentures due 2021, CUSIP No. 71713UAR3 had not been received. Adoption of the proposed amendments required consent of holders of at least 662/3% in principal amount of each series of debt securities. Because the required consents were